Cocaine and metabolites urinary excretion after controlled smoked administration

Journal of Analytical Toxicology

Volumn 31, Issue 8, 2007, Pages 462-468

  Huestis, Marilyn A ^a   Darwin, W David ^a   Shimomura, Eric ^b   Lalani, Shairose A ^b   Trinidad, Daniel V ^b   Jenkins, Amanda J ^c   Cone, Edward J ^d   Jacobs, Aaron J ^b,e   Smith, Michael L ^b   Paul, Buddha D ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Office of the Cuyahoga County Coroner   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Army Medical Department Center and School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; ECGONINE; ECGONINE METHYL ESTER; M HYDROXYBENZOYLECGONINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; SMOKING; URINALYSIS; URINARY EXCRETION;

EID: 36448971624     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.8.462     Document Type: Article

References (16)

1. Department of Health and Human Services. Mandatory guidelines and proposed revisions to mandatory guidelines for federal work-place drug testing programs. Fed. Regist. 69(71): 19644-19673 (2004).
2. Crack and cocaine. Department of Health and Human Services, NIDA InfoFacts May: 1-4 (2006).
3. World Drug Report, Vol. 2, United Nations, 2004, pp 422-427.
4. D.S. Isenschmid. Cocaine. In Principles of Forensic Toxicology, B.S. Levine, Ed. AACC Press, Washington, D.C., 2003, pp 207-228.
5. H.E. Hamilton, J.E. Wallace, E.L. Shimek, Jr., P. Land, S.C. Harris, and J.G. Christenson. Cocaine and benzoylecgonine excretion in humans. J. Forensic Sci. 22: 697-707 (1977).
6. J. Ambre, T.I. Ruo, J. Nelson, and S. Belknap. Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans. J. Anal. Toxicol. 12: 301-306 (1988).
7. E.J. Cone, A. Tsadik, J. Oyler, and W.D. Darwin. Cocaine metabolism and urinary excretion after different routes of administration. Ther. Drug Monit. 20: 556-560 (1998).
8. R.A. Jufer, A. Wstadik, S.L. Walsh, B.S. Levine, and E.J. Cone. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J. Anal. Toxicol. 24: 467-477 (2000).
9. D.S. Isenschmid, B.S. Levine, and Y.H. Caplan. A comprehensive study of the stability of cocaine and its metabolites. J. Anal. Toxicol. 13: 250-256 (1989).
10. K.L. Klette, G.K. Poch, R. Czarny, and C.O. Lau. Simultaneous GC-MS analysis of meta- and para-hydroxybenzoylecgonine and norbenzoylecgonine: a secondary method to corroborate cocaine ingestion using nonhydrolytic metabolites. J. Anal. Toxicol. 24: 482-488 (2000).
11. C.L. Hornbeck, K.M. Barton, and R.J. Czarny. Urine concentrations of ecgonine from specimens with low benzoylecgonine levels using a new ecgonine assay. J. Anal. Toxicol. 19: 133-138 (1995).
12. E.J. Cone, A.H. Sampson-Cone, W.D. Darwin, M.A. Huestis, and J.M. Oyler. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J. Anal. Toxicol. 27: 386-401 (2003).
13. A.J. Jenkins, R.M. Keenan, J.E. Henningfield, and E.J. Cone. Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration. J. Anal. Toxicol. 26: 382-392 (2002).
14. B.D. Paul, S. Lalani, T. Bosy, A.J. Jacobs, and M.A. Huestis. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. Biomed. Chromatogr. 19: 677-688 (2005).
15. K.L. Preston, D.H. Epstein, E.J. Cone, A.T. Wtsadik, M.A. Huestis, and E.T. Moolchan. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J. Anal. Toxicol. 26: 393-400 (2002).
16. D.E. Moody, K.M. Monti, and A.C. Spanbauer. Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20°C. J. Anal. Toxicol. 23: 535-540 (1999).